These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 11953331)

  • 1. Influence of treatment on morphological features of mucosal inflammation.
    Geboes K; Dalle I
    Gut; 2002 May; 50 Suppl 3(Suppl 3):III37-42. PubMed ID: 11953331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Focal enhanced gastritis and macrophage microaggregates in the gastric mucosa: potential role in the differential diagnosis between Crohn's disease and ulcerative colitis.
    Magalhães-Costa MH; Reis BR; Chagas VL; Nunes T; Souza HS; Zaltman C
    Arq Gastroenterol; 2014; 51(4):276-82. PubMed ID: 25591154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conventional therapy for moderate to severe inflammatory bowel disease: A systematic literature review.
    Damião AOMC; de Azevedo MFC; Carlos AS; Wada MY; Silva TVM; Feitosa FC
    World J Gastroenterol; 2019 Mar; 25(9):1142-1157. PubMed ID: 30863001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory bowel disease-related lesions in the duodenal and gastric mucosa.
    Danelius M; Ost A; Lapidus AB
    Scand J Gastroenterol; 2009; 44(4):441-5. PubMed ID: 19110988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Changing paradigm in the management of inflammatory bowel disease].
    Jang BI
    Korean J Gastroenterol; 2015 May; 65(5):268-72. PubMed ID: 25998972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective evaluation of upper gastrointestinal mucosal lesions in children with ulcerative colitis and Crohn's disease.
    Ruuska T; Vaajalahti P; Arajärvi P; Mäki M
    J Pediatr Gastroenterol Nutr; 1994 Aug; 19(2):181-6. PubMed ID: 7815240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upper gastrointestinal tract involvement of pediatric inflammatory bowel disease: A pathological review.
    Abuquteish D; Putra J
    World J Gastroenterol; 2019 Apr; 25(16):1928-1935. PubMed ID: 31086461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Focal gastric inflammatory infiltrates in inflammatory bowel diseases: prevalence, immunohistochemical characteristics, and diagnostic role.
    Parente F; Cucino C; Bollani S; Imbesi V; Maconi G; Bonetto S; Vago L; Bianchi Porro G
    Am J Gastroenterol; 2000 Mar; 95(3):705-11. PubMed ID: 10710061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Definition and evaluation of mucosal healing in clinical practice.
    Mazzuoli S; Guglielmi FW; Antonelli E; Salemme M; Bassotti G; Villanacci V
    Dig Liver Dis; 2013 Dec; 45(12):969-77. PubMed ID: 23932331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathological features of inflammatory bowel disease in childhood.
    Coulson WF
    Semin Pediatr Surg; 1994 Feb; 3(1):8-14. PubMed ID: 8062053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastroduodenal Crohn's disease: medical management.
    Tremaine WJ
    Inflamm Bowel Dis; 2003 Mar; 9(2):127-8; discussion 131. PubMed ID: 12769447
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical onset of the Crohn's disease after eradication therapy of Helicobacter pylori infection. Does Helicobacter pylori infection interact with natural history of inflammatory bowel diseases?
    Jovanovic IR; Milosavjevic TN; Jankovic GP; Micev MM; Dugalic PD; Saranovic D; Ugljesic MM; Popovic DV; Bulajic MM
    Med Sci Monit; 2001; 7(1):137-41. PubMed ID: 11208510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opposite effects of interferon regulatory factor 1 and osteopontin on the apoptosis of epithelial cells induced by TNF-α in inflammatory bowel disease.
    Tang R; Yang G; Zhang S; Wu C; Chen M
    Inflamm Bowel Dis; 2014 Nov; 20(11):1950-61. PubMed ID: 25208103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accumulation of mast cells and macrophages in focal active gastritis of patients with Crohn's disease.
    Furusu H; Murase K; Nishida Y; Isomoto H; Takeshima F; Mizuta Y; Hewlett BR; Riddell RH; Kohno S
    Hepatogastroenterology; 2002; 49(45):639-43. PubMed ID: 12063959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Focally enhanced gastritis in children with Crohn's disease and ulcerative colitis.
    Sharif F; McDermott M; Dillon M; Drumm B; Rowland M; Imrie C; Kelleher S; Harty S; Bourke B
    Am J Gastroenterol; 2002 Jun; 97(6):1415-20. PubMed ID: 12094859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histopathological evaluation of colonic mucosal biopsy specimens in chronic inflammatory bowel disease: diagnostic implications.
    Seldenrijk CA; Morson BC; Meuwissen SG; Schipper NW; Lindeman J; Meijer CJ
    Gut; 1991 Dec; 32(12):1514-20. PubMed ID: 1773958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [How to Optimally Use Currently Available Drugs in a Therapeutic Algorithm?].
    Kim YS
    Korean J Gastroenterol; 2018 Feb; 71(2):74-80. PubMed ID: 29471604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is histology useful for the assessment of the efficacy of immunosuppressive agents in IBD and if so, how should it be applied ?
    Geboes K
    Acta Gastroenterol Belg; 2004; 67(3):285-9. PubMed ID: 15587337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normal villous architecture with increased intraepithelial lymphocytes: a duodenal manifestation of Crohn disease.
    Patterson ER; Shmidt E; Oxentenko AS; Enders FT; Smyrk TC
    Am J Clin Pathol; 2015 Mar; 143(3):445-50. PubMed ID: 25696804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.